On the Prospect of “Daubertizing” Judicial Review of Risk Assessment.

Part of a special issue on science in the regulatory process. The Supreme Court, in Daubert v. Merrell Dow Pharmaceuticals, Inc., assigned a gatekeeper role to federal district courts hearing cases involving expert testimony; but assigning a similar role to courts engaged in judicial review of fede...

Full description

Bibliographic Details
Published in:Law & Contemporary Problems Vol. 66; no. 4; pp. 155 - 226
Main Author: McGarity, Thomas O.
Format: Article
Published: Duke University Autumn2003
Subjects:
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=502501401&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 502501401
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00239186
        LCP
      jtl: Law & Contemporary Problems
      issn: 00239186
      maglogo: N
    pubinfo:
      dt: Autumn2003
      vid: 66
      iid: 4
      pid: 588
      pub: Duke University
    artinfo:
      ui: 502501401
      ppf: 155
      ppct: 71
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
              size: 68.8MB
      tig:
        atl: On the Prospect of “Daubertizing” Judicial Review of Risk Assessment.
      aug:
        au: McGarity, Thomas O.
      su:
        United States. Environmental Protection Agency
        Environmental health
        Health risk assessment
        Judicial review
        Science & law
      sug:
        subj:
          United States. Environmental Protection Agency
          Environmental health
          Health risk assessment
          Judicial review
          Science & law
      keyword: United States -- Supreme Court -- Decisions
      ab: Part of a special issue on science in the regulatory process. The Supreme Court, in Daubert v. Merrell Dow Pharmaceuticals, Inc., assigned a gatekeeper role to federal district courts hearing cases involving expert testimony; but assigning a similar role to courts engaged in judicial review of federal agency risk assessments is an extremely bad idea. Having failed to rein in federal regulatory agencies by enacting sometimes strict regulatory-reform legislation, reformers are trying to secure regulatory relief in the courts by subtly granting a more activist role to judges, who are deemed to be more sympathetic to the objectives of the reformers than is Congress. The courts should strongly resist this call to reform protective health, safety, and environmental regulation to fit these judges' notions of the correct role for federal regulation in society.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N